Ropinirole XR (Extended Release) In Patients With Restless Legs Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

380

Participants

Timeline

Start Date

June 30, 2005

Study Completion Date

January 31, 2006

Conditions
Restless Legs Syndrome
Interventions
DRUG

Ropinirole Extended Release (XR)

Trial Locations (70)

12205

GSK Investigational Site, Albany

12308

GSK Investigational Site, Schenectady

12401

GSK Investigational Site, Kingston

13760

GSK Investigational Site, Endwell

19444

GSK Investigational Site, Lafayette Hill

22311

GSK Investigational Site, Alexandria

22911

GSK Investigational Site, Charlottesville

27607

GSK Investigational Site, Raleigh

29201

GSK Investigational Site, Columbia

29464

GSK Investigational Site, Mt. Pleasant

30106

GSK Investigational Site, Austell

30189

GSK Investigational Site, Woodstock

30338

GSK Investigational Site, Atlanta

30342

GSK Investigational Site, Atlanta

30534

GSK Investigational Site, Dawsonville

31201

GSK Investigational Site, Macon

33026

GSK Investigational Site, Pembroke Pines

33773

GSK Investigational Site, Largo

34996

GSK Investigational Site, Stuart

35007

GSK Investigational Site, Alabaster

35501

GSK Investigational Site, Jasper

38305

GSK Investigational Site, Jackson

40217

GSK Investigational Site, Louisville

43017

GSK Investigational Site, Dublin

43081

GSK Investigational Site, Westerville

44130

GSK Investigational Site, Cleveland

45236

GSK Investigational Site, Cincinnati

60062

GSK Investigational Site, Northbrook

63141

GSK Investigational Site, St Louis

66214

GSK Investigational Site, Lenexa

66606

GSK Investigational Site, Topeka

70808

GSK Investigational Site, Baton Rouge

73112

GSK Investigational Site, Oklahoma City

75231

GSK Investigational Site, Dallas

78229

GSK Investigational Site, San Antonio

80033

GSK Investigational Site, Wheat Ridge

80212

GSK Investigational Site, Denver

80909

GSK Investigational Site, Colorado Springs

84102

GSK Investigational Site, Salt Lake City

84121

GSK Investigational Site, Salt Lake City

85032

GSK Investigational Site, Phoenix

85201

GSK Investigational Site, Mesa

85351

GSK Investigational Site, Sun City

87108

GSK Investigational Site, Albuquerque

89119

GSK Investigational Site, Las Vegas

90277

GSK Investigational Site, Redondo Beach

90404

GSK Investigational Site, Santa Monica

91105

GSK Investigational Site, Pasadena

91325

GSK Investigational Site, Northridge

92103

GSK Investigational Site, San Diego

92801

GSK Investigational Site, Anaheim

93030

GSK Investigational Site, Oxnard

97219

GSK Investigational Site, Portland

98055

GSK Investigational Site, Renton

98226

GSK Investigational Site, Bellingham

98801

GSK Investigational Site, Wenatchee

99204

GSK Investigational Site, Spokane

99362

GSK Investigational Site, Walla Walla

85381 - 4828

GSK Investigational Site, Peoria

02459

GSK Investigational Site, Newton

T6G 2C8

GSK Investigational Site, Edmonton

V3K 3P4

GSK Investigational Site, Coquitlam

V3A 4H9

GSK Investigational Site, Langley

B3J 3T1

GSK Investigational Site, Halifax

L1S 2J5

GSK Investigational Site, Ajax

H2T 2N6

GSK Investigational Site, Montreal

H4J 1C5

GSK Investigational Site, Montreal

J1H 1Z1

GSK Investigational Site, Sherbrooke

G8Z 4K4

GSK Investigational Site, Trois-Rivières

S4P 0W5

GSK Investigational Site, Regina

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY